>20% organic sales growth in Q3. EBITDA up 12-25% for '23e-'25e. HOLD maintained, TP revised up to SEK 284 (272).
31 Oct 2023
Strong performance in Q3
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Strong performance in Q3
MedCap AB (MCAP:OME) | 0 0 0.0%
- Published:
31 Oct 2023 -
Author:
ABGSC Healthcare Research | Sten Gustafsson -
Pages:
13 -
>20% organic sales growth in Q3. EBITDA up 12-25% for '23e-'25e. HOLD maintained, TP revised up to SEK 284 (272).